Market Value156,679,000
Total Holdings39
File Date2022-11-10
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
TSVT / 2seventy bio, Inc.
GRTX / Galera Therapeutics, Inc.
SNOW / Snowflake Inc.
/ HashiCorp Inc
INCY / Incyte Corporation
BOLT / Bolt Biotherapeutics, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
ALXO / ALX Oncology Holdings Inc.
TCRR / Tcr2 Therapeutics Inc
SRPT / Sarepta Therapeutics, Inc.
CERS / Cerus Corporation
SLGC / Standard BioTools Inc.
CCXI / ChemoCentryx Inc
SYBX / Synlogic, Inc.
RLMD / Relmada Therapeutics, Inc.
KRTX / Karuna Therapeutics, Inc.
EAR / Eargo, Inc.
STSA / Satsuma Pharmaceuticals Inc
KDNY / Chinook Therapeutics Inc
RETA / Reata Pharmaceuticals Inc - Class A
OTIC / Otonomy Inc
SGEN / Seagen Inc
DBVT / DBV Technologies S.A. - Depositary Receipt (Common Stock)
ISEE / IVERIC bio Inc
NVTA / Invitae Corporation
AFMD / Affimed N.V.
BMRN / BioMarin Pharmaceutical Inc.
ACAD / ACADIA Pharmaceuticals Inc.
PACB / Pacific Biosciences of California, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
RANI / Rani Therapeutics Holdings, Inc.
EXEL / Exelixis, Inc.
FGEN / FibroGen, Inc.
KALV / KalVista Pharmaceuticals, Inc.
ILMN / Illumina, Inc.
HRMY / Harmony Biosciences Holdings, Inc.
XENE / Xenon Pharmaceuticals Inc.
TRDA / Entrada Therapeutics, Inc.
EXAI / Exscientia plc - Depositary Receipt (Common Stock)
ABCL / AbCellera Biologics Inc.
KOD / Kodiak Sciences Inc.
REPL / Replimune Group, Inc.
ONC / BeOne Medicines AG - Depositary Receipt (Common Stock)